The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Tara Seibert
No Relationships to Disclose
 
Jane McKenzie
Honoraria - Astellas Pharma
 
Lauren Howard
Consulting or Advisory Role - Tempus
 
Bilal Ashraf
No Relationships to Disclose
 
Jasmine Lu
No Relationships to Disclose
 
Kallie White
No Relationships to Disclose
 
Daniel George
Leadership - Capio BioSciences
Stock and Other Ownership Interests - BMS; Pfizer
Honoraria - Astellas Pharma; AstraZeneca; Axess Oncology; Bayer; Candel Therapeutics; Eisai; IDEOlogy Health; Janssen Oncology; Merck; Millennium Medical Publishing; Novartis; OncLive; Pfizer; Sumitomo; UroToday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Candel Theraputics; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Novartis; Pfizer; Physicans' Education Resource
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Convergent Therapeutics (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Expert Testimony - Exelixis
Travel, Accommodations, Expenses - Bayer; Exelixis; Merck; Novartis; Pfizer
 
Jeffrey Shevach
Stock and Other Ownership Interests - Pfizer
Honoraria - Bayer
Research Funding - AstraZeneca (Inst); Merck (Inst); Novartis (Inst)
 
Joseph Park
Consulting or Advisory Role - IDEOlogy Health; Medscape
Research Funding - Tempus
Travel, Accommodations, Expenses - Astellas Pharma; Merck
 
Dillon Cockrell
Honoraria - Med IQ; OncLive/MJH Life Sciences
 
Kristen Davis
No Relationships to Disclose
 
Michael Harrison
No Relationships to Disclose
 
Christopher Hoimes
Honoraria - Seagen
Consulting or Advisory Role - 2bPrecise; Amgen (Inst); Bristol-Myers Squibb; crispr therapeutics (Inst); Eisai; Foundation Medicine (Inst); Genentech/Roche; Merck Sharp & Dohme; NeoImmuneTech (Inst); Prometheus; Seagen
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Eisai; Genentech/Roche; Seagen
Research Funding - Alkermes (Inst); Astellas Pharma (Inst); BioNTech SE (Inst); BioNTech SE (Inst); BioNTech SE (Inst); BioNTech SE (Inst); Bristol Myers Squibb Foundation (Inst); crispr therapeutics (Inst); Dynavax Technologies (Inst); Janssen Oncology (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); NanoCarrier (Inst); Nektar (Inst); NeoImmuneTech (Inst); Novartis (Inst); seagen (Inst)
(OPTIONAL) Uncompensated Relationships - 2bPrecise (Inst)
 
Jordan Infield
No Relationships to Disclose
 
Matthew Labriola
No Relationships to Disclose
 
Hannah McManus
Consulting or Advisory Role - Astellas Pharma; Bayer; Johnson & Johnson/Janssen; Pfizer
 
Sundhar Ramalingam
No Relationships to Disclose
 
Andrew Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Boundless Bio; Bristol-Myers Squibb; Cytogen; Exelixis; GoodRx; Janssen; Merck; Myovant Sciences; Novartis; Pfizer; Precede Bio; Sumitomo Pharma Oncology
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); pathos (Inst); Pfizer (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc